460 related articles for article (PubMed ID: 33025046)
1. ACE2 expression in allergic airway disease may decrease the risk and severity of COVID-19.
Chhapola Shukla S
Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2637-2640. PubMed ID: 33025046
[TBL] [Abstract][Full Text] [Related]
2. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.
Kimura H; Francisco D; Conway M; Martinez FD; Vercelli D; Polverino F; Billheimer D; Kraft M
J Allergy Clin Immunol; 2020 Jul; 146(1):80-88.e8. PubMed ID: 32422146
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids.
O'Beirne SL; Salit J; Kaner RJ; Crystal RG; Strulovici-Barel Y
Respir Res; 2021 Jul; 22(1):200. PubMed ID: 34233672
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.
Peters MC; Sajuthi S; Deford P; Christenson S; Rios CL; Montgomery MT; Woodruff PG; Mauger DT; Erzurum SC; Johansson MW; Denlinger LC; Jarjour NN; Castro M; Hastie AT; Moore W; Ortega VE; Bleecker ER; Wenzel SE; Israel E; Levy BD; Seibold MA; Fahy JV
Am J Respir Crit Care Med; 2020 Jul; 202(1):83-90. PubMed ID: 32348692
[No Abstract] [Full Text] [Related]
6. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.
Finney LJ; Glanville N; Farne H; Aniscenko J; Fenwick P; Kemp SV; Trujillo-Torralbo MB; Loo SL; Calderazzo MA; Wedzicha JA; Mallia P; Bartlett NW; Johnston SL; Singanayagam A
J Allergy Clin Immunol; 2021 Feb; 147(2):510-519.e5. PubMed ID: 33068560
[TBL] [Abstract][Full Text] [Related]
7. Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases.
Yao Y; Wang H; Liu Z
Clin Exp Allergy; 2020 Dec; 50(12):1313-1324. PubMed ID: 32975865
[TBL] [Abstract][Full Text] [Related]
8. Soluble ACE2 and TMPRSS2 Levels in the Serum of Asthmatic Patients.
Lee JH; Lee CE; Yoo Y; Shin E; An J; Park SY; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
J Korean Med Sci; 2022 Feb; 37(8):e65. PubMed ID: 35226423
[TBL] [Abstract][Full Text] [Related]
9. Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients.
Saheb Sharif-Askari F; Goel S; Saheb Sharif-Askari N; Hafezi S; Al Heialy S; Hachim MY; Hachim IY; Mahboub B; Salameh L; Abdelrazig M; Elzain EI; Al-Muhsen S; Al-Hajjaj MS; Ratemi E; Hamid Q; Halwani R
Front Immunol; 2021; 12():796094. PubMed ID: 35111161
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and bronchial asthma: current perspectives.
Hojo M; Terada-Hirashima J; Sugiyama H
Glob Health Med; 2021 Apr; 3(2):67-72. PubMed ID: 33937568
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.
Takabayashi T; Yoshida K; Imoto Y; Schleimer RP; Fujieda S
Am J Rhinol Allergy; 2022 Jan; 36(1):115-122. PubMed ID: 34232770
[TBL] [Abstract][Full Text] [Related]
14. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Alabed M; Temsah MH; Al Heialy S; Hamid Q; Halwani R
Mol Ther Methods Clin Dev; 2020 Sep; 18():1-6. PubMed ID: 32537478
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
[TBL] [Abstract][Full Text] [Related]
16. Asthma and COVID-19: an update.
Adir Y; Saliba W; Beurnier A; Humbert M
Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911694
[TBL] [Abstract][Full Text] [Related]
17. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
[TBL] [Abstract][Full Text] [Related]
18. Targeting TMPRSS2 in SARS-CoV-2 Infection.
Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
[TBL] [Abstract][Full Text] [Related]
19. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
[TBL] [Abstract][Full Text] [Related]
20. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H
FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
